Enhanced’s 3D multi-omics platform delivers genetically validated targets for common diseases, accelerating development and increases rates of success in high-value indications Funding from BGF, ...

SAN FRANCISCO--(BUSINESS WIRE)--LatchBio is building data and pipeline infrastructure to help biotechnology teams access and analyze data at scale. The company is announcing today the release of ...

Multi-omics describes the integration of multiple high-throughput screening technologies based on genomics, proteomics, transcriptomics, single-cell transcriptomics, metabolomics, and more, which all ...

Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced it has ...